Originally, a data scientist at one of the leading life expectancy firms thought the coronavirus had increased the morality rate of seniors by six to 12% of the general population. But a more nuanced view now prevails – senior insureds are expected to die at six times the rate of the general population, not the higher estimate. Other mortality experts support the change in view as well, coming to believe that Covid-19 already may have killed sicker seniors earlier in the pandemic. As more guidance comes out on how to keep safe and isolate themselves, seniors, especially wealthier or healthier ones are more likely to survive. How are these revised estimates having an effect on the Life Settlements market?
Moderator: Donna Horowitz, Senior Editor, The Life Settlements Report, The Deal
Panelist: Nir Barzilai M.D., Director of the Einstein-Institute for Aging Research; Professor of Medicine and Genetics, Albert Einstein College of Medicine
Panelist: Jay Olshansky, Chief Scientist and Co-Founder, Lapetus Solutions Inc.
Panelist: Dan Ryan, Chief Science Officer, COIOS Research